Publication: Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis
No Thumbnail Available
Date
2015-04-01T00:00:00Z
Authors
Authors
SÜNBÜL, MURAT
Cagman, Zeynep
Gerin, Fethullah
ÖZGEN, ZÜLEYHA
Durmus, Erdal
Seckin, Dilek
Ahmad, Sarfraz
Uras, Fikriye
Agirbasli, Mehmet
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
ObjectivesAn increased risk for cardiovascular disease with psoriasis has been reported. Growth Arrest-Specific 6 (GAS6) amplifies pro-inflammatory endothelial cell activation via TAM receptors. However, it also inhibits inflammation by multiple mechanisms including phagocytosis. The objective of this study was to investigate whether plasma GAS6 levels are associated with conventional cardiometabolic (CM) risk factors in patients with psoriasis.
Description
Keywords
Citation
SÜNBÜL M., Cagman Z., Gerin F., ÖZGEN Z., Durmus E., Seckin D., Ahmad S., Uras F., Agirbasli M., -Growth Arrest-Specific 6 and Cardiometabolic Risk Factors in Patients with Psoriasis-, CARDIOVASCULAR THERAPEUTICS, cilt.33, ss.56-61, 2015